Adiponectin Signalling in Bone Homeostasis, with Age and in Disease

Overview

Journal Bone Res

Specialties Endocrinology
Orthopedics

Date 2021 Jan 8

PMID 33414405

Citations 19

Authors

Jonathan W Lewis

James R Edwards

Amy J Naylor

Helen M McGettrick

Affiliations

Soon will be listed here.

Abstract

Adiponectin is the most abundant circulating adipokine and is primarily involved in glucose metabolism and insulin resistance. Within the bone, osteoblasts and osteoclasts express the adiponectin receptors, however, there are conflicting reports on the effects of adiponectin on bone formation and turnover. Many studies have shown a pro-osteogenic role for adiponectin in in vivo murine models and in vitro: with increased osteoblast differentiation and activity, alongside lower levels of osteoclastogenesis. However, human studies often demonstrate an inverse relationship between adiponectin concentration and bone activity. Moreover, the presence of multiple isoforms of adiponectin and multiple receptor subtypes has the potential to lead to more complex signalling and functional consequences. As such, we still do not fully understand the importance of the adiponectin signalling pathway in regulating bone homeostasis and repair in health, with age and in disease. In this review, we explore our current understanding of adiponectin bioactivity in the bone; the significance of its different isoforms; and how adiponectin biology is altered in disease. Ultimately, furthering our understanding of adiponectin regulation of bone biology is key to developing pharmacological and non-pharmacological (lifestyle) interventions that target adiponectin signalling to boost bone growth and repair in healthy ageing, following injury or in disease.

Citing Articles

Positive causal association between diabetes and osteomyelitis, mediated by glycosylated hemoglobin and BMI: Evidence from a Mendelian randomization study.

Zhang K, Geng M, Zhang P Medicine (Baltimore). 2025; 104(10):e41688.

PMID: 40068038 PMC: 11902999. DOI: 10.1097/MD.0000000000041688.

Harnessing the diversity and potential of endogenous skeletal stem cells for musculoskeletal tissue regeneration.

Weldon K, Longaker M, Ambrosi T Stem Cells. 2025; 43(3).

PMID: 39945760 PMC: 11892563. DOI: 10.1093/stmcls/sxaf006.

The RGD region of bone sialoprotein affects metabolic activity in mice.

Nagasaki K, Nagasaki A, Taylor J, Kear B, Ma Y, Somerman M Front Dent Med. 2025; 4:1124084.

PMID: 39916931 PMC: 11797800. DOI: 10.3389/fdmed.2023.1124084.

Visfatin Enhances RANKL-Induced Osteoclastogenesis In Vitro: Synergistic Interactions and Its Role as a Mediator in Osteoclast Differentiation and Activation.

Ok C, Kwon R, Jang H, Bae M, Bae S Biomolecules. 2025; 14(12.

PMID: 39766208 PMC: 11673010. DOI: 10.3390/biom14121500.

Aging alters the effect of adiponectin receptor signaling on bone marrow-derived mesenchymal stem cells.

Liu H, Zhao Q, Liu S, Li B, Zheng Z, Liu Y Aging Cell. 2024; 24(2):e14390.

PMID: 39462849 PMC: 11822658. DOI: 10.1111/acel.14390.

References

Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J . Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999; 257(1):79-83. DOI: 10.1006/bbrc.1999.0255. View

Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y . Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol. 2000; 20(6):1595-9. DOI: 10.1161/01.atv.20.6.1595. View

Scherer P, Williams S, Fogliano M, Baldini G, Lodish H . A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem. 1995; 270(45):26746-9. DOI: 10.1074/jbc.270.45.26746. View

Mangge H, Almer G, Haj-Yahya S, Pilz S, Gasser R, Moller R . Preatherosclerosis and adiponectin subfractions in obese adolescents. Obesity (Silver Spring). 2008; 16(12):2578-84. DOI: 10.1038/oby.2008.439. View

Waki H, Yamauchi T, Kamon J, Ito Y, Uchida S, Kita S . Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J Biol Chem. 2003; 278(41):40352-63. DOI: 10.1074/jbc.M300365200. View

Hada Y, Yamauchi T, Waki H, Tsuchida A, Hara K, Yago H . Selective purification and characterization of adiponectin multimer species from human plasma. Biochem Biophys Res Commun. 2007; 356(2):487-93. DOI: 10.1016/j.bbrc.2007.03.004. View

Cawthorn W, Scheller E, Learman B, Parlee S, Simon B, Mori H . Bone marrow adipose tissue is an endocrine organ that contributes to increased circulating adiponectin during caloric restriction. Cell Metab. 2014; 20(2):368-375. PMC: 4126847. DOI: 10.1016/j.cmet.2014.06.003. View

Suchacki K, Tavares A, Mattiucci D, Scheller E, Papanastasiou G, Gray C . Bone marrow adipose tissue is a unique adipose subtype with distinct roles in glucose homeostasis. Nat Commun. 2020; 11(1):3097. PMC: 7303125. DOI: 10.1038/s41467-020-16878-2. View

L Newton A, Hanks L, Davis M, Casazza K . The relationships among total body fat, bone mineral content and bone marrow adipose tissue in early-pubertal girls. Bonekey Rep. 2013; 2:315. PMC: 3722749. DOI: 10.1038/bonekey.2013.49. View

10.

Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S . Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature. 2003; 423(6941):762-9. DOI: 10.1038/nature01705. View

11.

Yamauchi T, Iwabu M, Okada-Iwabu M, Kadowaki T . Adiponectin receptors: a review of their structure, function and how they work. Best Pract Res Clin Endocrinol Metab. 2014; 28(1):15-23. DOI: 10.1016/j.beem.2013.09.003. View

12.

Kadowaki T, Yamauchi T . Adiponectin receptor signaling: a new layer to the current model. Cell Metab. 2011; 13(2):123-4. DOI: 10.1016/j.cmet.2011.01.012. View

13.

Holland W, Miller R, Wang Z, Sun K, Barth B, Bui H . Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nat Med. 2010; 17(1):55-63. PMC: 3134999. DOI: 10.1038/nm.2277. View

14.

Obeid S, Hebbard L . Role of adiponectin and its receptors in cancer. Cancer Biol Med. 2013; 9(4):213-20. PMC: 3643674. DOI: 10.7497/j.issn.2095-3941.2012.04.001. View

15.

Wu Y, Li Y, Lange E, Croteau-Chonka D, Kuzawa C, McDade T . Genome-wide association study for adiponectin levels in Filipino women identifies CDH13 and a novel uncommon haplotype at KNG1-ADIPOQ. Hum Mol Genet. 2010; 19(24):4955-64. PMC: 2989895. DOI: 10.1093/hmg/ddq423. View

16.

Hug C, Wang J, Ahmad N, Bogan J, Tsao T, Lodish H . T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. Proc Natl Acad Sci U S A. 2004; 101(28):10308-13. PMC: 478568. DOI: 10.1073/pnas.0403382101. View

17.

Yamauchi T, Nio Y, Maki T, Kobayashi M, Takazawa T, Iwabu M . Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med. 2007; 13(3):332-9. DOI: 10.1038/nm1557. View

18.

Pang T, Chimen M, Goble E, Dixon N, Benbow A, Eldershaw S . Inhibition of islet immunoreactivity by adiponectin is attenuated in human type 1 diabetes. J Clin Endocrinol Metab. 2013; 98(3):E418-28. DOI: 10.1210/jc.2012-3516. View

19.

Luo X, Guo L, Yuan L, Xie H, Zhou H, Wu X . Adiponectin stimulates human osteoblasts proliferation and differentiation via the MAPK signaling pathway. Exp Cell Res. 2005; 309(1):99-109. DOI: 10.1016/j.yexcr.2005.05.021. View

20.

Berner H, Lyngstadaas S, Spahr A, Monjo M, Thommesen L, Drevon C . Adiponectin and its receptors are expressed in bone-forming cells. Bone. 2004; 35(4):842-9. DOI: 10.1016/j.bone.2004.06.008. View